LA JOLLA PHARMACEUTICAL CO Restructuring Costs
LA JOLLA PHARMACEUTICAL CO reported Restructuring Costs of $4.10 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2022-03-09
- LA JOLLA PHARMACEUTICAL CO restructuring costs for the quarter ending 2020-12-31 was -$1.70M.
- LA JOLLA PHARMACEUTICAL CO restructuring costs for the quarter ending 2020-09-30 was $0.00.
- LA JOLLA PHARMACEUTICAL CO restructuring costs for the quarter ending 2020-06-30 was $4.10M.
- LA JOLLA PHARMACEUTICAL CO restructuring costs for the quarter ending 2020-03-31 was $5.80M.
- LA JOLLA PHARMACEUTICAL CO restructuring costs for fiscal 2020 was $4.10M, a 29.31% decline from fiscal 2019.
- LA JOLLA PHARMACEUTICAL CO restructuring costs for fiscal 2019 was $5.80M, a 24.68% decline from fiscal 2018.
- LA JOLLA PHARMACEUTICAL CO restructuring costs for fiscal 2018 was $7.70M.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | -$1.70M derived: sum of 2 quarters · filed 2022-03-09 | $2.40M derived: sum of 3 quarters · filed 2022-03-09 | $4.10M 10-K · filed 2022-03-09 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $4.10M derived: sum of 2 quarters · filed 2020-11-09 | $5.80M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $4.10M 10-Q · filed 2020-08-06 | $5.80M 10-Q · filed 2020-08-06 | ||
| 2020-03-31 | $5.80M 10-Q · filed 2020-05-04 | |||
| 2019-12-31 | $5.80M 10-K · filed 2021-03-08 | |||
| 2018-12-31 | $7.70M 10-K · filed 2019-03-04 |